Doxiproct Plus, pommade rectale

7680389340152 CH-38934 pommade rectale
Doxiproct Plus, pommade rectale
Doxiproct Plus, pommade rectale
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
20
Selling units
20
Measure
g
Galenic form
pommade rectale
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/01/2026
Patient information leaflet
Français
27/01/2026
Patient information leaflet
Italien
27/01/2026
Summary of Product Characteristics
Allemand
02/06/2025
Summary of Product Characteristics
Français
02/06/2025
Summary of Product Characteristics
Italien
02/06/2025

Detailed composition

Substance Quantity Type Category
calcii dobesilas monohydricus
40.0 MG Substance Wirkstoff (Principe actif)
lidocaini hydrochloridum monohydricum
20.0 MG Substance Wirkstoff (Principe actif)
dexamethasoni acetas
0.25 MG Substance Wirkstoff (Principe actif)
polysorbatum 80
- Substance HNIDK
macrogolum 300
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
macrogolum 1500
- Substance HNIDK
macrogolum 4000
- Substance HNIDK
acidum citricum
- Substance HNIDK
alcohol cetylicus
60.0 MG Substance HBESI
propylenglycolum
309.0 MG Substance HBESI
E 310
- Substance ANTOX
E 320
150.0 UG Substance HBESI

Authorization holder

OM Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
38934
Drug name
Doxiproct Plus, pommade rectale
Galenic form
REKS
ATC Code
C05AA09
Authorization status
Z
Dispensing category
B
First authorization
22/04/1975
Authorization expiration date
31/12/9999
IT Number
02.09.2.
Domain
Human medicine

Package details

Description (FR)
Doxiproct Plus pommade rectale 20 g
Description (DE)
Doxiproct Plus Rektalsalbe 20 g
Market launch
22/04/1975
Narcotic (BTM)
No
Buy us a coffee Explore the data